Results 171 to 180 of about 68,698 (287)

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann   +7 more
wiley   +1 more source

Impacto de la mortalidad por cáncer

open access: yesRevista Colombiana de Cirugía, 2019
Mónica Bejarano
doaj   +1 more source

Author Correction: A concept-based interpretable model for the diagnosis of choroid neoplasias using multimodal data. [PDF]

open access: yesNat Commun
Wu Y   +15 more
europepmc   +1 more source

Possible causes of phenocopy syndrome in multiple endocrine neoplasia type 1

open access: diamond
D. A. Trukhina   +3 more
openalex   +1 more source

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the real‐world effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in an insured US population.
Lauren Wilson   +6 more
wiley   +1 more source

Diagnostic Approach to Early Barrett's Neoplasia: Japanese Perspective.

open access: yesDigestion
Shibagaki K   +7 more
europepmc   +1 more source

Risk of Vulvar HSIL and Penile Neoplasias in Anogenital Lichen Planus: A Case-Control Study. [PDF]

open access: yesJ Low Genit Tract Dis
Hieta NK   +5 more
europepmc   +1 more source

Effectiveness and adherence in a tirzepatide‐supported digital weight‐loss programme in Australia: A real‐world observational study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Obesity is a growing global health crisis; pharmacotherapies such as tirzepatide combined with multidisciplinary lifestyle support have shown promise but real‐world evidence in digital weight‐loss services (DWLSs) is limited. This retrospective study evaluated 6‐ and 12‐month weight loss, adherence and predictors of outcomes in an ...
Louis Talay   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy